Microbot Medical
MBOT
25 hedge funds and large institutions have $5.93M invested in Microbot Medical in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
26% more capital invested
Capital invested by funds: $4.72M → $5.93M (+$1.21M)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
9% more funds holding
Funds holding: 23 → 25 (+2)
1.26% more ownership
Funds ownership: 9.62% → 10.88% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$365K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$15.3K |
| 3 |
SPIA
Steward Partners Investment Advisory
New York
|
+$14.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.73K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$268 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$245K |
| 2 |
BlackRock
New York
|
-$169K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$13.1K |
| 4 |
Morgan Stanley
New York
|
-$10.2K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$28 |
MBOT Hedge Fund Activity: Q3 2020 in Review
25 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2020, worth a combined $5.93M — up 26% from $4.72M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MBOT positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Qube Research & Technologies (QRT), opening a new position worth an estimated $365K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $245K sold.
- 25 institutional investors held Microbot Medical (MBOT) as of Q3 2020, up from 23 in Q2 2020.
- Funds reported $5.93M of Microbot Medical stock for Q3 2020, up 26% quarter-over-quarter.
- 4 funds opened new Microbot Medical positions in Q3 2020 and 2 closed out, a net change of +2 holders.
- The largest Microbot Medical buyer in Q3 2020 was Qube Research & Technologies (QRT), an estimated $365K added.
- The largest Microbot Medical seller in Q3 2020 was Renaissance Technologies, an estimated $245K sold.
Based on aggregated 13F filings for Q3 2020.